“PSMA PET and MRI in Gynecological Cancers”
The goal of this research is to determine the accuracy of PSMA positron emission tomography (PET) and multi-parametric magnetic resonance (MR) imaging to detect the presence of gynecological cancer cells in the body.
Drug - PSMA-based 18F-DCFPyL PET tracer
PSMA-based 18F-DCFPyL PET tracer that will be used to determine the presence or absence of cancer
PSMA Positron Emission Tomography (PET) and Magnetic Resonance (MR) Imaging in Gynecological Cancers
NCT03302156
Qe1L3d